Prospecting for para-endogenous anxiolytics in the human microbiome: Some promising pathways.

Pharmacol Biochem Behav

Seed Health, Inc., 2100 Abbot Kinney Blvd, Unit G, Venice, CA 90291, United States of America; Swiss Institute for Allergy & Asthma Research, Herman-Burchard Strasse 9, 7265 Davos Wolfgang, Graubünden, Switzerland. Electronic address:

Published: November 2024

The gut microbiome is a vast, variable, and largely unexplored component of human biology that sits at the intersection of heritable and environmental factors, and represents a rich source of novel chemistry that is already known to be compatible with the human body. This alone would make it a promising place to search for new therapeutics, but recent work has also identified gut microbiome abnormalities in patients with a number of psychiatric disorders, including anxiety disorders-suggesting that not only treatments, but cures may lie therein. Here, we'll discuss two known "para-endogenous" anxiolytics-γ-hydroxybutyrate and the neurosteroid allopregnanolone-which have recently been discovered to be produced by the microbiome.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pbb.2024.173842DOI Listing

Publication Analysis

Top Keywords

gut microbiome
8
prospecting para-endogenous
4
para-endogenous anxiolytics
4
anxiolytics human
4
microbiome
4
human microbiome
4
microbiome promising
4
promising pathways
4
pathways gut
4
microbiome vast
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!